Home

Insights

Marksans Pharma Ltd P/E Ratio

Marksans Pharma Ltd P/E Ratio

download
stocks purchased

₹ 0.8 Cr

Volume transacted

stocks purchased

46.7 K

stocks traded

Image

Marksans Pharma Ltd

NSE: MARKSANS

PE

22.6

Last updated : 22 May 15:30 pm

Key Highlights

    The P/E Ratio of Marksans Pharma Ltd is 22.6 as of 22 May 15:30 pm .a1#The P/E Ratio of Marksans Pharma Ltd changed from 13.3 on March 2019 to 12 on March 2023 . This represents a CAGR of -2.04% over 5 years. a1#The Latest Trading Price of Marksans Pharma Ltd is ₹ 166.8 as of 22 May 15:30 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.7 to 27.7 in 5 years. This represents a CAGR of -0.71%a1# The PE Ratio of Automobile industry is 27.2. The PE Ratio of Finance industry is 13.6. The PE Ratio of IT - Software industry is 27.9. The PE Ratio of Pharmaceuticals industry is 27.7. The PE Ratio of Retail industry is 94.8. The PE Ratio of Textiles industry is 21.1. In 2023a1#The Market Cap of Marksans Pharma Ltd changed from ₹ 1017 crore on March 2019 to ₹ 3194 crore on March 2023 . This represents a CAGR of 25.72% over 5 years. a1#The Revenue of Marksans Pharma Ltd changed from ₹ 450.27 crore to ₹ 590.93 crore over 7 quarters. This represents a CAGR of 16.81% a1#The EBITDA of Marksans Pharma Ltd changed from ₹ 89.36 crore to ₹ 137.82 crore over 7 quarters. This represents a CAGR of 28.09% a1#The Net Profit of Marksans Pharma Ltd changed from ₹ 60.18 crore to ₹ 82.97 crore over 7 quarters. This represents a CAGR of 20.14% a1#The Dividend Payout of Marksans Pharma Ltd changed from 4.69 % on March 2019 to 22.03 % on March 2023 . This represents a CAGR of 36.26% over 5 years. a1#

Open Demat Account

Lead form image

+91

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

*By signing up you agree to our terms & conditions

×

P/E Ratio Over Time

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

P/E Ratio Over Time

Period
Mar '1913.3
Mar '204.7
Mar '218.6
Mar '2210.1
Mar '2312

Fundamental Metrics

Market Cap

7,558 Cr

EPS

7.0

P/E Ratio (TTM) *

22.6

P/B Ratio (TTM) *

3.8

Day’s High

168.0

Day’s Low

161.1

DTE *

0.1

ROE *

15.9

52 Week High

185.4

52 Week Low

70.2

ROCE *

20.2

* All values are consolidated

* All values are consolidated

Image

Marksans Pharma Ltd

NSE: MARKSANS

PRICE

166.8

1.85(1.12%)

stock direction

Last updated : 22 May 15:30

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of Marksans Pharma Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

Asset Value vs Market Value

Market Value

7,185

Asset Value

1,687

3.3 X

Value addition

* All values are in Rupees

PE Ratio Over Market Cap

Key Valuation Metric

Earnings

317 Cr

22.7 X

PE Ratio

Market Cap

₹7184Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio

PS Ratio

PB Ratio

Earnings

317 Cr

22.7 X

PE Ratio

Market Cap

₹7184Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Marksans Pharma Ltd PE Ratio Calculation

  • The Price-to-Earnings (PE) ratio, also known as the P/E Ratio, is a fundamental financial metric used to assess the valuation of a company's stock in relation to its earnings performance. For Marksans Pharma Ltd, the PE Ratio is calculated as follows:

P/E Ratio

=

Market Capitalization

Net Income

  • Given the current market conditions, Marksans Pharma Ltd's Share Price stands at 166.8. The Earnings per Share (Diluted) for the trailing twelve months (TTM) ending in 2024-05-22T00:00:00 is 7.0. Substituting the values into the formula, PE Ratio becomes as follows: PE Ratio = 166.8/ 7.0= 22.65.

P/E Ratio

=

Stock Price

Earning Per Share

  • This indicates that Marksans Pharma Ltd's stock is trading at approximately 22.65 times its earnings per share for the trailing twelve months. Alternatively, the PE Ratio can also be computed using the company's overall financial performance: PE Ratio = Market Cap / Net Income. Where Market Cap represents the total market capitalization of the company, and Net Income signifies the total earnings after expenses and taxes.

Understanding Marksans Pharma Ltd’s PE Ratio (BSE: MARKSANS)

    The Price-to-Earnings (PE) ratio, used to assess Marksans Pharma Ltd's stock (BSE: MARKSANS), indicates how many years it would take for the company to earn back the stock price. If a company earns ₹2 per share annually and its stock trades at ₹30, the PE ratio is 15, signifying a 15-year payback period assuming steady earnings. Earnings fluctuate, affecting the payback period, Growing earnings shorten the recovery time while declining earnings extend it. Shareholders favor shorter payback periods, preferring lower PE stocks. Among stocks with the same PE ratio, faster-growing businesses are preferred. A company with losses makes the PE ratio meaningless. Peter Lynch introduced the PEG ratio to compare stocks with different growth rates, dividing the PE ratio by the growth rate. A company is considered fairly valued when its PE ratio matches its growth rate. The PE ratio, applicable across industries, measures stock valuation based on earnings power. It indicates how quickly an investment can be recouped. Unlike the PB ratio, which assesses valuation based on the balance sheet, the PE ratio focuses on earnings. Overall, the PE ratio provides insights into stock valuation, aligning with investors' preference for faster returns.

×

Market Cap Over Time

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Market Cap Over Time

Period
Mar '191017
Mar '20569
Mar '212045
Mar '221864
Mar '233194

* All values are a in crore

×

Revenue Over Time

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Revenue Over Time

Period
Jun '22450
Sep '22467
Dec '22497
Mar '22497
Jun '23510
Sep '23550
Dec '23591

* All values are a in crore

×

EBITDA Over Time

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

EBITDA Over Time

Period
Jun '2289
Sep '2294
Dec '2294
Mar '22121
Jun '23112
Sep '23133
Dec '23138

* All values are a in crore

×

Net Profit Over Time

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Net Profit Over Time

Period
Jun '2260
Sep '2260
Dec '2262
Mar '2283
Jun '2370
Sep '2384
Dec '2383

* All values are a in crore

×

Dividend Payout Over Time

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Dividend Payout Over Time

Period
Mar '195
Mar '2011
Mar '2110
Mar '2210
Mar '2322

* All values are a in %

About Marksans Pharma Ltd

About Marksans Pharma Ltd

    The Company is primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulation. The Company's research and development facilities are located in Verna, Goa and R & D center in Navi Mumbai.

Marksans Pharma Ltd News Hub

News

Marksans Pharma declare Quarterly Result

Marksans Pharma will hold a meeting of the Board of Directors of the Company on 30 May 202...

Read more

13 May 2024 15:04

News

Marksans Pharma's Goa unit concludes USFDA inspection with observations

Marksans Pharma announced that a routine current Good Manufacturing Practices (cGMP) inspe...

Read more

18 Apr 2024 11:45

News

Marksans Pharma declines after US FDA issues Form 483 with 5 observations to Goan plant

The US drug regulator had conducted a routine current Good Manufacturing Practices (cGMP) ...

Read more

18 Apr 2024 11:52

News

Marksans Pharma jumps after Q3 PAT climbs 34% YoY to Rs 83 cr

Revenue from operations increased 22.15%YoY to Rs 586.12 crore in Q3 FY24, driven by marke...

Read more

13 Feb 2024 15:41

News

Marksans Pharma to declare Quarterly Result

Marksans Pharma will hold a meeting of the Board of Directors of the Company on 13 Februar...

Read more

17 Jan 2024 17:29

News

Marksans Pharma receives upgrade in credit ratings

Marksans Pharma has received upgrade in credit ratings for bank facilities from India Rati...

Read more

08 Dec 2023 16:03

Product Composition by Percentage (Revenue)

FAQs for PE of Marksans Pharma Ltd

What is Marksans Pharma Ltd current share price?

The current market price of Marksans Pharma Ltd as of May 22, 2024 is ₹166.80.

What is Marksans Pharma Ltd's market cap?

Marksans Pharma Ltd's market capitalisation stood at ₹7,184 Cr as of May 22, 2024

What are Marksans Pharma Ltd's total net assets?

According to Marksans Pharma Ltd's most recent financial filings, the company's net assets total ₹1686.6 Cr.

Is Marksans Pharma Ltd making a profit or loss?

Marksans Pharma Ltd's net Profit as of May 22, 2024 is close to ₹317 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199